Abbott announced it has received European CE Mark approval for the Esprit below-the-knee (BTK) everolimus-eluting resorbable ...

A summary of clinical outcomes from the Vascular and Endovascular Access Society (SAVE)* patient registry in Brazil, ...

A summary of my center’s experience in the WAVE pivotal trial, what makes the WRAPSODY Cell-Impermeable Endoprosthesis (CIE) ...

Patient throughput and management of GI bleeds, from initial presentation through definitive management. Gastrointestinal (GI ...

A Q&A addressing common questions around coding, payment models, and value-based care alignment for percutaneous transmural ...

Dr. Jabbour discusses the evolution of transradial access for neurointervention, his collaboration with Wills Eye Hospital on ...

Otsuka Medical Devices Co., Ltd. announced that the Paradise ultrasound renal denervation (uRDN) system has received manufacturi ...

Impact of the NCD on referrals and volumes of transfemoral carotid artery stenting, the multidisciplinary approach to evaluation and treatment, considering patient factors and patient preference, ...

Reflections on what is lost and gained when a well-designed trial produces unexpected results.

The introduction of mechanical thrombectomy and PERTs has ushered in a new era of pulmonary embolism management, involving standardized, team-based, clinical decision-making pathways; expanded ...

Cook Medical announced that the FDA has granted approval for the company to initiate an investigational device exemption (IDE ...

After the 2018 Journal of the American Heart Association (JAHA) meta-analysis suggesting an early mortality signal in ...